Auspex Pharmaceuticals Inc (NASDAQ:ASPX)

100.88
Delayed Data
As of Apr 24
 -0.01 / -0.01%
Today’s Change
14.75
Today|||52-Week Range
100.94
+92.23%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization161.0K30.0K12.0K49.0K
 
 
 
 
 
 
Operating ExpensesGross Income-161.0K-30.0K-12.0K-49.0K
 
 
 
 
 
General Expenses5.8M13.4M13.2M55.4M
 
 
 
 
 
Research And Development4.1M11.7M10.0M42.9M
 
 
 
 
 
Total Operating Expenses6.0M13.4M13.2M55.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.0M-13.4M-13.2M-55.5M
 
 
 
 
 
Extraordinary Credit3.2M0.000.00--
 
 
Extraordinary Charge0.00-195.0K-1.9M-3.6M
 
 
 
 
Pre-Tax Equity Earnings-------4.3M
 
 
Interest Expense On Debt35.0K1.5M506.0K2.6M
 
 
 
 
 
Other Expenses0.000.000.0051.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.8M-15.1M-15.6M-64.7M
 
 
 
 
 
Income Taxes0.000.000.00-5.2M
 
 
Minority Interest0.000.000.00-39.0K
 
 
Net Income-2.8M-15.1M-15.6M-59.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS132.00132.0042.1K22.2M
 
 
 
 
 
Shares To Calculate EPS Diluted132.00132.0042.1K22.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$21,318.00-$114,485.00-$371.00-$2.68
 
 
 
 
 
EPS Diluted-$21,318.00-$114,485.00-$371.00-$2.68
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account